CGB 0.00% 2.1¢ cann global limited

Hunt added there is also the potential for greater innovation in...

  1. 766 Posts.
    lightbulb Created with Sketch. 167
    Hunt added there is also the potential for greater innovation in the area of bioavailability, citing Canntab’s instant and extended release hard-pill formulations as examples, but “those types of products take a lot of research and investment”.

    Looks like CGB have a real winner on their hands

    Zess looks like we will be years a head of the pack

 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.